[1] Kim HD, Lim YS, Han S, et al. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology, 2015,148:1371-1382.
[2] Bae KT. Optimization of contrast enhancement in thoracic MDCT. Radiol Clin North Am, 2010, 48:9-29.
[3] Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol, 1994, 163:323-331.
[4] Wald C, Russo MW, Heimbach JK, et al. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology, 2013, 266:376-382.
[5] Hwang SH, Yu JS, Kim KW, et al. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr, 2008, 32:39-45.
[6] Holland AE, Hecht EM, Hahn WY, et al. Importance of small (< or=20 mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhoticliver: evaluation and comparison with whole explanted liver. Radiology, 2005, 237:938-944.
[7] Tsuboyama T, Onishi H, Kim T, et al. Hepatocellular carcinoma: hepatocyte-selective enhancement atgadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology, 2010, 255:824-833.
[8] Sano K, Ichikawa T, Motosugi U, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology, 2011, 261:834-844.
[9] Krinsky GA, Lee VS, Theise ND, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology, 2001, 219:445-454.
[10] Peterson MS, Baron RL, Marsh JW Jr, et al. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology, 2000, 217:743-749.
[11] de Ledinghen V, Laharie D, Lecesne R, et al. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol, 2002, 14: 159-165.
[12] Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol, 2006, 101:513-523.
[13] Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma:diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015:275: 97-109.
[14] Wu LM, Xu JR, Gu HY, et al. Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? Dig Dis Sci, 2013, 58:3313-3325.
[15] Sherman M, Bruix J. Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice. Hepatology, 2015, 61:433-437.
[16] Torbenson M, Schirmacher P. Liver cancer biopsy - back to the future?! Hepatology, 2015, 61:431-433. |
